Asset Value Investors (AVI) Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage More Constructively with Shareholders

LONDON--(BUSINESS WIRE)--Asset Value Investors Limited (“AVI”) today announced an update to its public campaign regarding Rohto Pharmaceutical Co., Ltd. (TSE: 4527, “Rohto”), as a follow-up to its ongoing campaign, “Awakening Rohto”, launched last year and aimed at enhancing the company’s corporate value. AVI has published a detailed presentation on a dedicated website (www.AwakeningRohto.com). Since initiating its investment in June 2024, AVI has sought to engage in constructive dialogue with